Literature DB >> 31764452

Factors Associated With Delirium Following Electroconvulsive Therapy: A Systematic Review.

Takashi Tsujii1,2, Takahito Uchida1, Takefumi Suzuki3, Masaru Mimura1, Jinichi Hirano1, Hiroyuki Uchida1,4.   

Abstract

OBJECTIVES: Delirium following electroconvulsive therapy (ECT) has been a clinical challenge, which, however, has not been investigated through a systematic literature review. The objective of this study was to systematically synthesize available evidence regarding factors associated with post-ECT delirium.
METHODS: We conducted a systematic literature search for any type of original investigations that reported risk factors of post-ECT delirium, using PubMed.
RESULTS: The literature search identified 43 relevant articles. One study found an association between catatonic feature and increased risk of postictal delirium. Five studies reported that the presence of cerebrovascular disease, Parkinson disease, or dementia was related to higher incidence of post-ECT delirium. Incidence of post-ECT course delirium was increased with bitemporal stimulation (3 studies). One study showed that ultrabrief pulse ECT reduced reorientation time following seizure compared with brief pulse ECT. High stimulus intensity resulted in more prolonged reorientation time after ECT than lower stimulus intensity (2 studies). Longer seizure length was significantly associated with post-ECT delirium in 1 study. Eight studies that examined postictal delirium in association with medications used, including lithium, did not show any consistent finding in their relationships. Four studies showed decreased incidence of postictal delirium in those receiving dexmedetomidine.
CONCLUSIONS: Limited evidence suggests that catatonic feature, cerebrovascular disease, Parkinson disease, dementia, bitemporal electrode placement, high stimulus intensity, or longer seizure length are associated with an increased risk of post-ECT delirium. Moreover, dexmedetomidine and ultrabrief pulse ECT seem to have preventive effects of post-ECT delirium.

Entities:  

Mesh:

Year:  2019        PMID: 31764452     DOI: 10.1097/YCT.0000000000000606

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  6 in total

1.  The Role of Acetylcholinesterase Inhibitors in the Treatment of Prolonged Postelectroconvulsive Therapy Delirium.

Authors:  Brianna Gutowski; Emily Bomasang-Layno
Journal:  Case Rep Psychiatry       Date:  2022-05-30

Review 2.  Clinical use of lithium salts: guide for users and prescribers.

Authors:  Leonardo Tondo; Martin Alda; Michael Bauer; Veerle Bergink; Paul Grof; Tomas Hajek; Ute Lewitka; Rasmus W Licht; Mirko Manchia; Bruno Müller-Oerlinghausen; René E Nielsen; Marylou Selo; Christian Simhandl; Ross J Baldessarini
Journal:  Int J Bipolar Disord       Date:  2019-07-22

3.  The incidence of prolonged post-electroconvulsive therapy delirium: A retrospective study.

Authors:  Sandeep Grover; Ajay Kumar; Subho Chakrabarti; Ajit Avasthi
Journal:  Indian J Psychiatry       Date:  2020-03-17       Impact factor: 1.759

4.  Prevalence and Predictors of Postictal Confusion After Electroconvulsive Therapy.

Authors:  Pichai Ittasakul; Phathamon Jarernrat; Phern-Chern Tor
Journal:  Neuropsychiatr Dis Treat       Date:  2021-02-02       Impact factor: 2.570

5.  Impact of Sevoflurane and Thiopental Used Over the Course of Electroconvulsive Therapy: Propensity Score Matching Analysis.

Authors:  Taisuke Yatomi; Takahito Uchida; Akihiro Takamiya; Masataka Wada; Shun Kudo; Kazuki Nakajima; Hana Nishida; Bun Yamagata; Masaru Mimura; Jinichi Hirano
Journal:  Front Hum Neurosci       Date:  2022-07-08       Impact factor: 3.473

6.  Dexmedetomidine Regulates the miR-146a-5p/NF-κB Axis to Alleviate Electroconvulsive Therapy-Induced Cognitive Impairments.

Authors:  Xiaohui Zhou; Peipei Si; Li Wang; Huiqun Jia
Journal:  Comput Math Methods Med       Date:  2022-10-04       Impact factor: 2.809

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.